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Abstract
The soil-borne plant pathogen Fusarium oxysporum causes life-threatening invasive fusariosis in immunocompromised
individuals. The mechanism of infection in mammalian hosts is largely unknown. In the present study we show that the
symptoms of disseminated fusariosis caused by F. oxysporum in immunosuppressed mice are remarkably similar to those
reported in humans. Distinct fungal structures were observed inside the host, depending on the infected organ. Invasive
hyphae developed in the heart and kidney, causing massive colonization of the organs. By contrast, chlamydospore-like
survival structures were found in lung, spleen and liver. Systemically infected mice also developed skin and eye infections, as
well as thrombosis and necrosis in the tail. We further show that F. oxysporum can disseminate and persist in the organs of
immunocompetent animals, and that these latent infections can lead to lethal systemic fusariosis if the host is later
subjected to immunosuppressive treatment.
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Introduction
Fungi of the genus Fusarium are important plant pathogens
commonly found in soil, water and decaying organic matter [1]. In
addition, Fusaria can cause a broad spectrum of diseases in
humans, ranging from superficial or localized infections in healthy
hosts to lethal disseminated fusarioses in immunocompromised
patients [2]. Today, Fusarium is the second major cause of mould
infections in immunocompromised patients after aspergillosis, and
the incidence is increasing [3]. Fusarium species are among the
most drug resistant fungal pathogens [4,5,6] and thus associated
with high morbidity and mortality rates [7,8]. Rapid diagnosis is
essential for successful antifungal therapy and survival of the
patient. In many cases the entry sites of disseminated Fusarium
infections remain unclear, but reported portals of entry include
onychomycosis, the respiratory tract (particularly paranasal
sinuses), the gastrointestinal tract, and the central venous lines.
However, few model systems for evaluating virulence and
pathogenesis of this group of fungi have been described. Here
we developed a murine infection model and use it to demonstrate
that the infection symptoms caused by disseminated Fusarium
infection in immunosuppressed mice are remarkably similar to
those reported in humans [2,3,9]. One of the most frequent
symptoms of infection by Fusarium species is the development of
skin lesions, which are most commonly found on the extremities.
They are described as painful subcutaneous nodules that can result
in thrombosis and tissue necrosis [10]. Skin lesions are often the
only source of diagnostic material, because blood cultures remain
negative in many cases, in spite of blood dissemination [11].
Therefore, it is of interest to characterize the clinicopathological
features of skin lesions and their role in Fusarium infection and to
establish them in the diagnosis and management protocols of
fusariosis. Previous studies suggest that Fusarium can cause skin
lesions even in immunocompetent individuals, and that upon
immunosuppression these foci can lead to the development of
invasive and disseminated fusariosis [12]. It has been recom-
mended that patients to undertake severe immunosuppressive
therapy should undergo a thorough skin evaluation before
initiation of therapy [9].
Soil-borne Fusarium oxysporum is the causal agent of vascular wilt,
a devastating disease affecting a large variety of economically
important crops worldwide [13]. F. oxysporum also causes invasive
infections in immunosuppressed individuals, being the second
most frequent species of the genus after Fusarium solani, [3,14]. The
incidence of invasive fungal infections leading to significant
morbidity and mortality is rising because of the increase of the
pool of immunocompromised patients caused by a dramatically
increase number of solid organ transplants and the use of newer
and more potent chemotherapeutic agents [15]. This is coupled
with an increase in the number of reports of severe cases of
invasive fusariosis often with lethal outcomes, due to the broad
resistance to antifungal drugs [12,16]. F. oxysporum infections are
often misdiagnosed as a result of the histopathological similarities
with Aspergillus or non-Aspergillus hyalohyphomycoses [2,12,17,18].
Previous work established that a tomato pathogenic isolate of F.
oxysporum f.sp. lycopersici can cause disseminated infection in
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immunocompromised mice [19]. The ability to cause disease in
both plants and mammals makes F. oxysporum a unique multihost
pathogen for studying fungal infection across different host
kingdoms. To date several knockout mutants have been tested
for virulence in immunosuppressed mice [19,20,21,22,23].
In the present study we used the F. oxysporum-mouse model to
investigate infectious growth of F. oxysporum in mammals. We
found that F. oxysporum develops distinct invasive structures,
including hyphae, microconidia and chlamydospores, depending
on the infected organ. We further show that F. oxysporum can cause
thrombosis and necrosis in the tails of immunosuppressed mice,
which can serve as model to study fungal skin infection in
mammals. Finally we present strong evidence for dissemination of
F. oxysporum in immunocompetent animals. Our results suggest that
latent organ infections without macroscopic disease symptoms can
initiate lethal systemic fusariosis, if the host is later subjected to
immunosuppressive treatment.
Methods
F. oxysporum Isolate and Culture Conditions
F. oxysporum f.sp. lycopersici wild type strain 4287 was originally
obtained from J. Tello, University of Almeria, Spain and stored as
a glycerol microconidial suspension at 280 C. The pathogenicity
of this wild type isolate on tomato plants is routinely confirmed by
plant infection assays [24]. Fusarium conidia were cultured in
potato dextrose broth at 28uC and 150 rpm for 4 days. For
preparation of challenge inocula, microconidia were isolated by
filtration as described previously [24], collected by centrifugation,
washed, and resuspended in sterile physiological saline. The
conidial concentration was adjusted with a hemocytometer to the
desired density. The actual inoculum level was confirmed by
plating serial dilutions on potato dextrose agar plates (PDA;
Sigma) and incubating for 24 h at 28uC.
Animal Infections
All animal experimentation was done in accordance with UK
Home Office regulations and was approved by both the UK
Home Office and the University of Aberdeen ethical review
committee.
Female BALB/c mice (Harlan, UK; 6–8 weeks old) were
maintained in groups of up to 6 animals per cage. All mice were
fed sterilized laboratory chow and water ad libitum. Each animal
was individually marked and was weighed daily. Immunosuppres-
sion was performed by intraperitoneal injection of 150 mg
cyclophosphamide (Sigma) per kg body weight, which was
repeated every 3 days thereafter. Depending on the experiment,
the immunosuppressive treatment initiated either on day 3 prior to
infection (day 23), on the same day of infection (day 0), or 3 or 7
days after infection (day 3 or 7, respectively).
Mice were infected by intravenous injection of 0.2 ml of a
conidia suspension into the lateral tail vein. Mice were observed
for up to 28 days post-challenge and were humanely terminated
when they showed signs of severe illness and/or their body weight
reduced by more than 20% of their initial body weight. Data were
used to construct Kaplan-Meier survival curves, with differences
determined by log rank statistics using GraphPad Prism 5.
Tissue Burden and Histopathology
When mice were culled the hearts, lungs, kidneys, spleens and
livers were aseptically removed, and one half of each organ was
weighed and homogenized in 0.5 ml sterile saline. Ten fold serial
dilutions of this homogenate were spread onto PDA. Plates were
incubated at 28uC, colonies were counted after 48 h and CFU per
gram for each organ were calculated. Fungal colony counts were
converted to Log10 values and compared using the analysis of
variance test. Data were analysed with the software GraphPad
Prism 5.
The remaining halves of the organs were embedded in Cryo-M-
bed (Bright Instruments, UK) and flash frozen. Sections (8 mm)
were stained with Periodic acid-Schiff (PAS)-hematoxylin and
examined by light microscopy. In addition, samples of spleen tissue
Figure 1. Effect of inoculum size and timing of immunosup-
pression on the severity of F. oxysporum infection. (A) BALB/c
mice (n = 6) were inoculated intravenously with F. oxysporum microco-
nidia. Immunosuppressive treatment (150 mg cyclophosphamide per
kg body weight) was initiated three days prior to infection (day 23) and
repeated every 3 days thereafter. Survival was recorded for 20 days. An
inoculum dose of 26106 microconidia caused significantly lower
mortality than 26107 microconidia (p = 0.0016); 106 microconidia
caused significant lower mortality than 26106 microconidia
(p = 0.0024). (B) BALB/c mice (n = 6) were inoculated with 26107
microconidia, and immunosuppressive treatment was initiated either
on day 23 or on day 0, and repeated every 3 days thereafter. Survival
was recorded over 20 d. (C) Fungal burdens in mice immunosuppressed
on day 0 and inoculated with 26107 microconidia. On each of the
indicated days post-infection (dpi), one animal was sacrificed and organ
homogenates quantified.
doi:10.1371/journal.pone.0089920.g001
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from infected immunocompetent mice were homogenized, treated
with KOH and stained with 25 mg ml21 Calcofluor White (CFW)
to visualize fungal structures.
Results
Effect of Inoculum Size and Timing of
Immunosuppressive Treatment on the Severity of F.
oxysporum Systemic Infection
The effect of inoculum size on systemic infection by F. oxysporum
in immunosuppressed mice was investigated. Intravenous inocu-
lation with 26107 microconidia led to rapid development of
systemic infection, with all mice becoming severely ill within 24 h
(Fig. 1A). An inoculum of 26106 microconidia also caused 100%
mortality, however disease progression was significantly slower
(p = 0.0016), with all mice dying within 5 days. Finally, inoculation
with 106 microconidia caused a significant drop in mortality, with
only two of the six infected mice succumbing to infection within
the 20 d observation period (p = 0.0024).
We next tested the effect of timing of immunosuppression on
disease severity. When the immunosuppressive treatment was
initiated 3 d prior to infection (day 23) and repeated every 3 days
thereafter, all mice succumbed to infection (Fig. 1A & B). By
contrast, a delay in the start of the immunosuppression (day 0) led
to a significant reduction in mortality (p = 0.0009) (Fig. 1B). Fungal
burdens in the heart, lung and liver declined by 1–2 orders of
magnitude over 18 days following inoculation, but remained at the
same level in the kidneys and declined only slightly in the spleen
(Fig. 1C).
F. oxysporum Displays Distinct Invasion Strategies in
Different Organs of the Host
Variations in the fungal burdens observed (Fig. 1C) prompted us
to conduct a histopathological analysis of the invasive growth of F.
oxysporum in mice subjected to immunosuppressive treatment on
day 0, and every 3 days thereafter. PAS-hematoxylin-staining of
tissue sections revealed striking differences in fungal development
between different organs. At 24 h post inoculation, a significant
number of microconidia had germinated in the heart and kidney
(Fig. 2A & D), whereas only ungerminated microconidia were
observed in lung, spleen and liver (data not shown). After 4 d post-
inoculation (dpi), branched fungal hyphae had developed in the
heart and kidney (Fig. 2B & E), leading to the production of large
Figure 2. F. oxysporum displays distinct growth morphologies in different organs. PAS-hematoxylin-staining of tissue sections from
different organs. Mice were subjected to immunosuppressive treatment on day 0, and every 3 days thereafter. Organs were obtained on day 1 (A, D),
4 (B, E, G, H, I) or 14 (C, F) after infection with 26107 microconidia: heart (A–C), kidney (D–F), lung (G), spleen (H), liver (I). Fungal structures are
indicated by arrows. G, microconidial germlings; M, mycelium; C, chlamydospores. Scale bar = 50 mm.
doi:10.1371/journal.pone.0089920.g002
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mycelial colonies and the complete invasion of the infected tissue
area at 16 dpi (Fig. 2C & F). Invasive growth was particularly
aggressive in the kidneys (Fig. 3), where the fungal biomass was
detectable macroscopically on the surface of the organ (Fig. 3A &
C). By contrast, invasive growth was not detected in the lung,
spleen and liver. Instead, F. oxysporum developed chlamydospore-
like structures, which were detected at 4 dpi and remained visible
at 16 dpi (Fig. 2G, H & I).
F. oxysporum Causes Thrombosis and Necrosis in Tails
and Infections in Eyes of Immunosuppressed Mice
We noted that the immunosuppressed mice infected with F.
oxysporum developed bulges and swellings which appeared at
multiple sites along the tail, not restricted to the site of inoculation
(Fig. 4B). Some of these swellings subsequently turned into open
lesions (Fig. 4C & E). In addition, some mice displayed
macroscopic symptoms of necrosis at the tail. The necrotic tissue
was initially visible as a black region at the tip (Fig. 4D & E) which
spread upwards along the tail, in some cases leading to loss of the
tip (Fig. 4F). Calcofluor white (CFW) staining of tissue samples
obtained from the open wounds revealed the presence of
chlamydospores and hyphae of F. oxysporum (Fig. 4G & H).
Another observation associated with the presence of F. oxysporum
in the immunosuppressed mice was the development of infection
symptoms around and within the eye (Fig. 4I–M). The presence of
fungal structures in the infected eye tissue was confirmed
microscopically (Fig. 4N).
Figure 3. Invasive growth of F. oxysporum in the kidney. (A) Fungal biomass on the surface of an aseptically removed kidney from a mouse
subjected to immunosuppressive treatment on day 0, and every 3 days thereafter. The kidney was obtained 20 d after infection with 106
microconidia. Visible fungal lesions are indicated by arrows. (B) Kidney cross section from a mouse subjected to immunosuppressive treatment on
day 0, and every 3 days thereafter. The kidney was obtained 20 d post-infection with 106 microconidia. Bright areas correspond to fungal biomass
stained with the chitin-binding dye Calcofluor White (CFW). The white box indicates the area used for the tissue section shown in C. (C) PAS-
hematoxylin staining of a tissue section. The area of invasive mycelial growth is surrounded by arrows. M, mycelium. Scale bars are indicated.
doi:10.1371/journal.pone.0089920.g003
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F. oxysporum Disseminates and Persists in
Immunocompetent Mice
Inoculation F. oxysporum typically leads to 70–100% mortality in
immunosuppressed mice, whereas immunocompetent animals fail
to display detectable signs of illness ([19] and this work, data not
shown). Thus, we investigated whether F. oxysporum was able to
disseminate and persist in an immunocompetent host. Strikingly,
fungal burdens at 4 dpi in immunocompetent mice inoculated
with 26107 microconidia were similar or only slightly lower than
in animals subjected to immunosuppressive treatment on day 0,
and every 3 days thereafter (Fig. 5A). F. oxysporum microconidia
and germlings were observed in the heart, lung, kidney, spleen and
liver of immunocompetent animals (Fig. 5C–F). At 11 dpi the
fungal burdens in immunocompetent animals had declined by
approximately two orders of magnitude in most of the organs, but
remained relatively high (,105 CFU per g tissue) in the spleen
(Fig. 5B). Indeed, PAS-hematoxylin and CFW staining confirmed
the presence of chlamydospores, as well as germinated and
ungerminated microconidia in different organs of infected animals
at 4 and 11 dpi (Fig. 4G).
Figure 4. F. oxysporum causes infection in the tails and eyes of immunosuppressed mice. Mice were subjected to immunosuppressive
treatment on day 0, and every 3 days thereafter. (A) Tail of a non-infected immunosuppressed BALB/c mouse. (B–E) Tails of immunosuppressed BALB/
c mice intravenously inoculated with 106 conidia at 10 d post-infection. Macroscopic symptoms are indicated by arrows: swellings (B, D), open lesions
(C), necrosis (D, E), and loss of the tip (E). (F, G) CFW staining of tissue samples taken from the lesion shown in (C). Fungal structures are indicated by
arrows. H, hyphae; C, chlamydospores. (H–L) Infection of the eye tissue in immunosuppressed mice infected with F. oxysporum. (H) Uninoculated
mouse; (I–K) mice inoculated with 106 conidia at 10 dpi. (L) CFW staining of an eye removed from an immunosuppressed mouse infected with F.
oxysporum. H, hyphae. Scale bar = 50 mm (F, G); 1 mm (L).
doi:10.1371/journal.pone.0089920.g004
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Persistence of F. oxysporum in the Immunocompetent
Host can Lead to Subsequent Systemic Infection upon
Immunosuppressive Treatment
The presence of fungal propagules in the organs of immuno-
competent mice even at .10 dpi suggests that F. oxysporum can
develop resting structures such as chlamydospores, but also
actively growing mycelium to persist within the immunocompetent
host. Such a host might subsequently become susceptible to
invasive fusariosis if the immune system is disrupted. When
immunocompetent mice inoculated with F. oxysporum were
subjected to immunosuppressive treatments starting at either 3
or 7 dpi and repeated every 3 days thereafter, one mouse in each
group died at 16 and 15 dpi, respectively (Fig. 6A). Fungal burden
was determined in different organs from one of the killed mice,
revealing high counts of fungal propagules (Fig. 5B). Tissue
sections confirmed the presence of invasive mycelial growth in
multiple organs, including heart, kidney spleen and liver,
indicative of systemic fusariosis (Fig. 5C–F).
Discussion
Fungi of the genus Fusarium are common soil inhabitants and
notorious plant pathogens, and have long been recognized as
etiologic agents of focal infections of the skin, nails, and cornea of
humans [25]. Moreover, invasive Fusarium infections in immuno-
suppressed patients are associated with high mortality rates [7,8].
Rapid antifungal therapy, achieved by a prompt diagnosis, is
essential for survival of these patients. A critical step is the
identification of Fusarium, which is often made difficult by some
histopathological similarities with Aspergillus. Infections caused by
both Fusarium and Aspergillus are characterized by hyaline
branching septate hyphae at acute angles, which invade the blood
vessels causing thrombosis and tissue infarction [18,26]. There-
fore, a detailed characterization of the invasive behaviour of
Fusarium within the host, including growth and development of
fungal structures formed by the pathogen and associated with
disease, is required and will have important consequences for the
diagnosis and management of fusariosis. Here we used the mouse
model to investigate Fusarium infection in mammals. The
usefulness of the animal model is highlighted by the finding that
the disease symptoms observed in mice are remarkably similar to
those reported in human fusariosis [2,3,9].
A key result of this study is that F. oxysporum displays distinct
invasion strategies in different organs of mice. While the fungus
initiated hyphal growth 24 h after inoculation in the kidney and
the heart, no such growth was detected in the spleen, liver or lung.
Instead, chlamydospore-like structures were formed in these
organs. This novel finding represents an important advance in
our understanding of Fusarium infections in mammals. Chlamydo-
spores are thick-walled cells generally developed through the
modification of hyphal and conidial cells. Their formation is
induced by aging or unfavorable environmental conditions such as
low temperatures or carbon starvation. Chlamydospores represent
the principal structure for long-time survival during unfavorable
periods in the soil, and play an important role as primary
inoculum for plant root infection [27,28,29,30,31]. Our findings
highlight the importance of detailed histopathological analysis of
infection structures, in addition to routine determination of fungal
Figure 5. F. oxysporum disseminates and persists in immunocompetent mice. (A) Fungal burdens were determined at day 4 post-infection
for groups of 3 BALB/c mice, either immunocompetent or immunosuppressed on day 0 and every 3 days thereafter, and intravenously infected with
26107 microconidia. (B) Fungal burdens in infected immunocompetent mice sacrificed at 11 d post-infection. (C–F) PAS-hematoxylin-staining of
tissue sections obtained from different organs of immunocompetent mice sacrificed at 4 d post-infection. (C) Heart, (D) lung, (E) kidney, (F) liver. (G)
Spleen sample from an infected immunocompetent mouse sacrificed at 11 d post-infection was homogenized, KOH-treated and stained with CFW to
visualize fungal structures (indicated by arrows). G, microconidial germlings; C, chlamydospores. Scale bar = 50 mm.
doi:10.1371/journal.pone.0089920.g005
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burden. For example, kidneys contained reduced fungal burdens
compared to the spleen, but microscopic analysis revealed massive
mycelial invasive growth in this organ, which in some instances
was even visible macroscopically on the organ surface. Thus,
although fungal burden is a useful parameter for assessing fungal
dissemination in the host, it fails to provide detailed information
on the impact of filamentous pathogens on the infected organs. It
was reported previously that during F. solani or A. fumigatus
infection, quantitative culture led to underestimation of absolute
fungal burden as compared to non-culture-based methods such as
quantitative PCR or determination of galactomannan levels by
enzyme immunoassays (EIAs) [32,33,34,35]. In an inhalational rat
model of invasive pulmonary aspergillosis (IPA), both real-time
nucleic acid sequence-based amplification (NASBA) and qPCR
showed a progressive increase of fungal biomass in lung tissue,
whereas CFU counts were stable over time [36].
A frequent symptom associated with Fusarium infections is the
development of superficial skin lesions, described as subcutaneous
nodules that can result in thrombosis and tissue necrosis [10]. In
more than 60% of disseminated Fusarium infections skin biopsies of
affected patients revealed necrosis of skin papules [37] and
microvessel thrombosis associated with fungal hyphae [10]. Here
we found that infection of immunosuppressed mice by F. oxysporum
led to macroscopic symptoms in the tail, including necrosis of the
skin, swellings and wounds and even loss of the tail tip.
Microscopic analysis of the skin lesions confirmed that the nodules
Figure 6. F. oxysporum persistence in immunocompetent mice can lead to systemic infection and death upon subsequent
immunosuppression. (A) BALB/c mice (n = 6) were intravenously inoculated with 26107 microconidia. Immunosuppressive treatment was initiated
either on day 3 or 7 post-infection and repeated every 3 days thereafter. Survival was recorded over 20 d. Fungal burdens (B) and PAS-hematoxylin-
staining (C–F) of organ sections from a mouse inoculated with 26107 F. oxysporum microconidia and subjected to immunosuppressive treatment
starting at 7 dpi. The mouse that died was culled at 15 dpi. Organs: heart (C), kidney (D), spleen (E), liver (F). M, mycelium; C, chlamydospores. Scale
bar = 50 mm.
doi:10.1371/journal.pone.0089920.g006
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contained both chlamydospores and hyphae of F. oxysporum. CFW
staining proved to be highly useful for detection of progressive
systemic fusariosis in the mouse system, and could therefore be
used as a rapid diagnostic tool in immunocompromised patients.
Because skin lesions often appear during early stages of Fusarium
infection before the disease spreads to the trunk and the
extremities, they are crucial for the diagnosis and management
of fusariosis, allowing rapidly initiation of a specific treatment in
order to prevent progression of skin lesions and further necrosis.
F. oxysporum keratitis is one of the most important causes of
corneal ulcers, ocular morbidity and visual loss in developing
nations [38]. It is also a common type of infection caused by F.
solani in immunocompetent individuals worldwide
[39,40,41,42,43,44]. A previous study on disseminated F. solani
infection via inoculation of microconidia in the lateral tail vein of
immunocompetent mice reported disease symptoms both in intra-
ocular structures and in neighbouring muscles [45] Here we
provide evidence for the presence of fungal biomass around and
within the eyes of immunosuppressed mice, associated with
disseminated F. oxysporum infection. This result supports the view
that fungal keratitis should be established as part of the diagnostic
protocol for disseminated Fusarium infections in order to prevent a
delay in diagnosis or inadequate treatment, which may lead to loss
of the affected eye. Further, we observed that mice affected by
disseminated F. oxysporum infection showed a ‘‘twister’’ phenotype
indicating a possible infection of the brain. Supporting this idea,
analysis of fungal burden in the brain of an animal displaying a
twister phenotype showed the presence of fungal biomass (data not
shown), suggesting that F. oxysporum is able to enter the mouse
brain.
Initiation of immunosuppressive treatment at day 23 led to
death of all infected animals, while mortality was significantly
lower when immunosuppression was started in parallel to
infection. Thus, the immune status of the host has a major effect
on the severity of infection by F. oxysporum. Importantly, we show
here for the first time that F. oxysporum can also disseminate and
persist in immunocompetent individuals. Unexpectedly, fungal
burdens in immunocompetent mice at 4 dpi were only slightly
lower than in immunosuppressed animals, with microconidia and
germlings observed in the heart, lung, kidney, spleen and liver of
immunocompetent animals even after more than 10 dpi. The
finding that F. oxysporum can persist in an immunocompetent
mammalian host is highly relevant, because these fungal foci could
lead to subsequent systemic infection upon immunosuppressive
treatment. Indeed, one mouse in each group later succumbed to
fungal infection. We conclude that invasive fusariosis in these
animals was caused by chlamydospore-like structures which had
persisted in the organs, suggesting that latent fungal survival
structures have the potential to initiate invasive mycelial growth
once the immune system is no longer effective.
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